Teleflex Incorporated (TFX)
Market Closed
1 Sep, 20:00
$
140. 48
-1.57
-1.1052%
$
6.18B Market Cap
- P/E Ratio
0.54% Div Yield
564,966 Volume
- Eps
$ 142.05
Previous Close Want to track TFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
TFX closed today lower at $140.48, a decrease of -1.1052% from yesterday's close, completing a monthly increase of 1.613% or $2.23. Over the past 12 months, TFX stock gained 14.7712%.
TFX pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next announced payment will be in In 4 weeks on Sep 30, 2026 for a total of $0.34.
The last earnings report, released on Apr 30, 2026, missed the consensus estimates by -2.99%. On average, the company has fell short of earnings expectations by -3.3733%, based on the last three reports.
Teleflex Incorporated has completed 5 stock splits, with the recent split occurring on Jun 17, 1997.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Should You Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Interventional expansion and improved leverage support its outlook, while currency volatility remains a key risk.
Zacks | 4 days ago
TFX or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks | 6 days ago
Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?
Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressure keep execution risks in focus.
Zacks | 1 week ago
Teleflex Incorporated Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 1,879 | $324,043.6 | $256,878.11 | -$67,165.49 | -20.73% |
 Curtis Ellergodt Rothschild Investment LLC | 289 | $35,362.05 | $39,529.42 | $4,167.37 | 11.78% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 3,772 | $478,106 | $509,144.56 | $31,038.56 | 6.49% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 33 | $4,027.35 | $4,452.03 | $424.68 | 10.54% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1,004 | $144,517.72 | $134,074.16 | -$10,443.56 | -7.23% |
Teleflex Incorporated Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Jason Bednar Piper Sandler | 41.64 | $5,618.05 | $5,618.05 | - | - |
Teleflex Incorporated (TFX) FAQ
What is the stock price today?
The current price is $140.48.
On which exchange is it traded?
Teleflex Incorporated is listed on NYSE.
What is its stock symbol?
The ticker symbol is TFX.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.54%.
What is its market cap?
As of today, the market cap is 6.18B.
Has Teleflex Incorporated ever had a stock split?
Teleflex Incorporated had 5 splits and the recent split was on Jun 17, 1997.
Teleflex Incorporated Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Jason Weidman CEO | NYSE Exchange | 879369106 CUSIP |
| US Country | 15,500 Employees | 14 Aug 2026 Last Dividend | 17 Jun 1997 Last Split | 18 Feb 1988 IPO Date |
Overview
Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.
Products and Services
- Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
- Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
- Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
- Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
- Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
- Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
- Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
- Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.
Contact Information
Address: 550 East Swedesford Road
Phone: 610 225 6800
Website: https://www.teleflex.com
